BNY Mellon Global Real Return Fund LSE:BPCR Holdings History
BNY Mellon Global Real Return Fund's BioPharma Credit PLC Holding Summary
As of 2025-04-30, BNY Mellon Advantage Funds, Inc. held 13.33 Mil shares of BioPharma Credit PLC(LSE:BPCR), totaling $11.38 Mil. This investment constitutes 3.54% of their stock portfolio, and BNY Mellon Advantage Funds, Inc. now holds 1.18% of the outstanding BioPharma Credit PLC(LSE:BPCR) stock.
The initial trade took place in 2020Q3. And since then BNY Mellon Global Real Return Fund has made 2 purchases of LSE:BPCR, at an average price of $0.98, for a total of 23.63 Mil shares. In addition, there have been 4 sales at an average price of $0.88 for 10.30 Mil shares. Based on historical transaction data and LSE:BPCR's current price of $0.88, BNY Mellon Global Real Return Fund's estimated gain on his LSE:BPCR holdings is $-2.30 Mil, reflecting a -9.97% gain to date.
BNY Mellon Global Real Return Fund LSE:BPCR ($0.88) Holding Chart
BNY Mellon Global Real Return Fund LSE:BPCR ($0.88) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
